Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellegy Seeks A Buyer Or Partner For Cellegesic Following FDA “Approvable” Letter

This article was originally published in The Pink Sheet Daily

Executive Summary

"Approvable" letter indicates the need for additional studies to provide more evidence of the efficacy of the nitroglycerin ointment for anal fissures.

You may also be interested in...



Missing Clinical Trial Data: "Mixed Model" Approach Gains Ground At FDA

Clinical trial sponsors should adopt a mixed statistical model to cope with missing data rather than relying on the "last observation carried forward" model that was formerly perceived as regulators' favorite

Missing Clinical Trial Data: "Mixed Model" Approach Gains Ground At FDA

Clinical trial sponsors should adopt a mixed statistical model to cope with missing data rather than relying on the "last observation carried forward" model that was formerly perceived as regulators' favorite

Cellegy Contraception Gel Study Continues After Firm Drops HIV Trial

Phase III Nigerian trial was halted after data monitoring committee determines the microbicide was unlikely to show convincing evidence it protects against HIV.

Related Content

Topics

UsernamePublicRestriction

Register

LL1125120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel